Gaucher disease: Recommendations on diagnosis, evaluation, and monitoring

Archives of Internal Medicine

Volumn 158, Issue 16, 1998, Pages 1754-1760

  Charrow, Joel ^a,j   Esplin, Joan A ^b   Gribble, T John ^c   Kaplan, Paige ^d   Kolodny, Edwin H ^e   Pastores, Gregory M ^e   Scott, C Ronald ^f   Wappner, Rebecca S ^g   Weinreb, Neal J ^h   Wisch, Jeffrey S ⁱ  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g INDIANA UNIVERSITY   (United States)

^h University Hospital   (United States)

ⁱ NEWTON WELLESLEY HOSPITAL   (United States)

^j CHILDREN'S MEMORIAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ALBUMIN; ALGLUCERASE; ALKALINE PHOSPHATASE; BILIRUBIN; CALCIUM; GLUCOSYLCERAMIDE; IMIGLUCERASE; IRON; LIVER ENZYME;

ANTIBODY DETECTION; AUTOSOMAL RECESSIVE INHERITANCE; CLINICAL PROTOCOL; DIAGNOSTIC APPROACH ROUTE; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME REPLACEMENT; GAUCHER DISEASE; GENE MUTATION; GENETIC COUNSELING; GENOTYPE; HUMAN; JEW; LABORATORY TEST; PATHOPHYSIOLOGY; PATIENT SCHEDULING; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

BONE AND BONES; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; MUTATION;

EID: 17744421004     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.16.1754     Document Type: Review

References (70)

1. Brady RO, Kanfer JN, Shapiro D. Metabolism of glucocerebrosides, II: evidence of an enzymatic deficiency in Gaucher disease. Biochem Biophys Res Commun. 1965;18:221-225.
2. Patrick AD. Short communications: a deficiency of glucocerebrosidase in Gaucher disease. Biochem J. 1965;97:17C-18C.
3. Desnick RJ. Gaucher disease: a century of delineation and understanding. Prog Clin Biol Res. 1982;95:1-30.
4. Parkin JL, Brunning RD. Pathology of the Gaucher cell. Prog Clin Biol Res. 1982;95:151-175.
5. Frederickson DS, Sloan HR. Glucosylceremide lipidoses: Gaucher disease. In: Stansbury JB, Wyngaarden JB, Frederickson DS, eds. The Metabolic Basis of Inherited Disease. 3rd ed. New York, NY: McGraw-Hill Book Co; 1978:730-759.
6. Sibille A, Eng CM, Kim S-J, et al. Phenotype/ genotype correlations in Gaucher disease type 1: clinical and therapeutic implications. Am J Hum Genet. 1993;52:1094-1101.
7. Barton NW, Brady RO, Dambrosia JM, et al. Replacement therapy for inherited enzyme deficiency: macrophage-targeted glucocerebrosidase for Gaucher disease. N Engl J Med. 1991; 324:1464-1470.
8. Zimran A, Elstein D, Levy-Lahad E, et al. Replacement therapy with imiglucerase for type I Gaucher disease. Lancet. 1995;345:1479-1480.
9. Grabowski GA, Barton NW, Pastores G, et al. Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminaled glucocerebrosidase from natural and recombinant sources. Ann Intern Med. 1995;122:33-39.
10. Rosenthal DI, Doppelt SH, Mankin HJ, et al. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics. 1995;96:629-637.
11. National Institutes of Health Technology Assessment Conference Statement. Gaucher disease: current issues in diagnosis and treatment. JAMA 1996;275:548-553
12. Beutler E, Saven A. Misuse of marrow examination in the diagnosis of Gaucher disease. Blood. 1990;76:646-648.
13. Beutler E, Kuhl W, Trinidad F, Teplitz RL, Nadler H. Beta-glucosidase activity in fibroblasts from homozygotes and heterozygotes for Gaucher disease. Am J Hum Genet. 1971;23:62-68.
14. Grabowski GA, Saal HM, Wenstrup RJ, Barton NW. Gaucher disease: a prototype for molecular medicine. Crit Rev Oncol Hematol. 1996;23:25-55.
15. Alterini R, Rigacci L, Stefanacci S. Pseudo-Gaucher cells in the bone marrow of a patient with centrocytic nodular non-Hodgkin's lymphoma. Haemotologica. 1996;81:282-283.
16. Kattlove HE, Williams SC, Gaynor E, et al. Gaucher cells in chronic myelocytic leukemia: an acquired abnormality. Blood. 1969;3:379.
17. Sorge J, West C, Westwood B, Beutler E. Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA. Proc Natl Acad Sci U S A. 1985;82:7289-7293.
18. Tsuji S, Choudary PV, Martin BM, et al. Nucleotide sequence of cDNA containing the complete coding sequence for human lysosomal glucocerebrosidase. J Biol Chem. 1986;261:50-53.
19. Horowitz M, Wilder S, Horowitz Z, et al. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics. 1996;4:87-96.
20. Beutler E, Gelbart T. Glucocerebrosidase (Gaucher disease). Hum Mutat 1996;8:207-213.
21. Barranger JA, Rice E, Sakallah SA, et al. Enzymatic and molecular diagnosis of Gaucher disease. Clin Lab Med. 1995;15:899-913.
22. Horowitz M, Zimran A. Mutations causing Gaucher disease. Hum Mutat. 1994;3:1-11.
23. Zimran A, Sorge J, Gross E, et al. Prediction of severity of Gaucher's disease by identification of mutations of DNA level. Lancet. 1989;2:349-352.
24. Grabowski GA. Gaucher disease: enzymology, genetics, and treatment. In: Harris H, Hirschhorn K, eds. Advances in Human Genetics. New York, NY: Plenum Press; 1993:377-441.
25. Zimran A, Kay A, Gelbart T, et al. Gaucher disease: clinical, laboratory, radiologic, and genetic features of 53 patients. Medicine (Baltimore). 1992; 71:337-353.
26. Kolodny EH, Firon N, Eyal N, Horowitz M. Mutation analysis of Ashkenazi Jewish family with Gaucher disease in three successive generations. Am J Med Genet. 1990;36:467-472.
27. Erikson A. Gaucher disease: Norrbottnian type (III) - neuropaediatric and neurobiological aspects of clinical patterns and treatment. Acta Paediatr Scand Suppl. 1986;326:1-42.
28. Grewal RP, Doppelt SH, Thompson MA, et al. Neurologic complications of nonneuronopathic Gaucher's disease. Arch Neurol. 1991;48:1271-1272.
29. Erikson A, Wahlberg I. Gaucher disease: Norrbottnian type - ocular abnormalities. Acta Ophthalmol (Copenh). 1985;63:221-225.
30. Kaplan P, Mazur A, Manor O, et al. Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase. J Pediatr. 1996;129:149-153.
31. Zevin S, Abrahamov A, Hadas-Halpern I, et al. Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy. QJM. 1993;86:565-573.
32. Tanner JM, Goldstein H, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity and stages of puberty. Arch Dis Child. 1976;51:170-179.
33. Parker RI, Barton NW, Read EJ, Brady RO. Hematologic Improvement in a patient with Gaucher disease on long-term enzyme replacement therapy: evidence for decreased splenic sequestration and improved red blood cell survival. Am J Hematol. 1991;38:130-137.
34. Zimran A, Aker M, Matzner Y. Abnormal neutrophil chemotaxis in patients with Gaucher disease [abstract]. Blood. 1991;78:104a.
35. Pastores GM, Sibille AR, Grabowski GA. Enzyme therapy in Gaucher disease type 1: dosage, efficacy and adverse effects in 33 patients treated for 6 to 24 months. Blood. 1993;82: 408-416.
36. Barranger JA, Ginns EI. Glucosylceramide lipidoses: Gaucher disease. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic Basis of Inherited Disease. 6th ed. New York, NY: McGraw-Hill Book Co; 1989:1677-1698.
37. Lee RE. The pathology of Gaucher disease, In: Desnick RJ, Gatt S, Grabowski GA, eds. Gaucher Disease: A Century of Delineation and Research. New York, NY: Alan R Liss Inc; 1982:177-217.
38. James SP, Stromeyer FW, Chang C, Barranger JA. Liver abnormalities in patients with Gaucher disease. Gastroenterology. 1981;80:126-133.
39. Elstein D, Hadas-Halpern I, Azuri Y, Abrahamov A, Bar-Ziv Y, Zimran A. Accuracy of ultrasonography in assessing spleen and liver size in patients with Gaucher disease: comparison to computed tomographic measurements. J Ultrasound Med. 1997;16:209-211.
40. Glenn D, Thurston D, Garver P, Beutler E. Comparison of magnetic resonance imaging and ultrasound in evaluating liver size in Gaucher patients. Acta Haematol. 1994;92:187-189.
41. Glass RBJ, Poznanski AK, Young S, Urban MA. Gaucher disease of the liver: CT appearance. Pediatr Radiol. 1987;17:417-418.
42. Hill SC, Damaska BM, Ling A, et al. Gaucher disease: abdominal MR imaging findings in 46 patients. Radiology. 1992;184:561-566.
43. Skeletal disease among patients in the ICGG registry. ICGG Registry Updates. 1994:1-4.
44. Pastores GM, Wallenstein S, Desnick RJ, Luckey MM. Bone density in type I Gaucher disease. J Bone Miner Res. 1996;11:1801-1807.
45. Mankin HJ, Doppelt SH, Rosenberg AE, et al. Metabolic bone disease in patients with Gaucher disease. In: Avioli LV, Krane SM, eds. Metabolic Bone Disease. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1990:730-752
46. Pastores GM, Einhorn TA. Skeletal complications of Gaucher disease: pathophysiology, evaluation, and treatment. Semin Hematol. 1995;32 (suppl 1):20-27.
47. Stowens DW, Teitelbaum SL, Kahn AJ, et al. Skeletal complications of Gaucher disease. Medicine (Baltimore). 1985;64:310-322.
48. Belmatoug N. Bilette de Villemeur for the Comité d'Evaluation du Traitement par la Ceredase 7: skeletal response to enzyme replacement therapy of type 1 Gaucher disease - a preliminary report of the French experience. Semin Hematol. 1995;32 (suppl 1):33-38.
49. Rosenthal DI, Doppelt SH, Mankin HJ, et al. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics. 1995;96:629-637.
50. Hermann G, Shapiro RS, Abdelwahab IF, et al. MR imaging in adults with Gaucher disease type I: evaluation of marrow involvement and disease activity. Skeletal Radiol. 1993;22:247-251.
51. Rademakers RP. Radiologic evaluation of Gaucher bone disease. Semin Hematol. 1995;32 (suppl 1):14-19.
52. Rosenthal DI, Scott JA, Barranger J, et al. Evaluation of Gaucher disease using magnetic resonance imaging. J Bone Joint Surg Am. 1986;68: 802-808.
53. Rosenthal DI, Barton NW, McKusick KA, et al. Quantitative imaging of Gaucher disease. Radiology. 1992;185:841-845.
54. Johnson LA, Hoppel BE, Gerard EL, et al. Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease. Radiology. 1992;182:451-455.
55. Veredese CL, Graham OC, Hodler-McShane CA, Harnet NE, Barton NW. Gaucher's disease: a pilot study of the symptomatic responses to enzyme replacement therapy. J Neurosci Nurs. 1993; 25:296-301.
56. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, Mass: New England Medical Center, The Health Institute; 1993.
57. Richards SM, Olson TA, McPherson JM. Antibody response in patients with Gaucher disease after repeated infusions with macrophage-targeted glucocerebrosidase. Blood. 1993;82:1402-1405.
58. Iancu TC, Shiloh H. Iron and fibrogenesis in Gaucher disease. J Hepatol. 1996;25(suppl 1):115.
59. Iancu TC, Shiloh H. Gaucher cells, iron, and liver fibrosis. Gastroenterology. 1996;110(suppl 4): 1215.
60. Schiano TD, Grinberg M, Nawabi I, Grabowski G. Blue nasal secretions: a presentation of Gaucher's disease and concurrent hemosiderosis. Am J Hematol. 1993;44:219-220.
61. Laine F, Guyader D, Turlin B, Moirrand R, Deugnier Y, Brissot P. Hyper-ferritinemia and Gaucher disease. Gastroenterol Clin Biol. 1996;20: 512-513.
62. Berribi A, Malnick SD, Vorst EJ, Stein D. High incidence of factor XI deficiency in Gaucher's disease. Am J Hematol. 1992;40:153.
63. Humphries JE, Hess CE. Gaucher's disease and acquired coagulopathy. Am J Hematol. 1994;45: 347-348.
64. Yates P, Morse C, Standen GR. Gaucher's disease and acquired coagulopathy. Clin Lab Haematol. 1992;14:331-334.
65. Billett HH, Rizvi S, Sawitzky A. Coagulation abnormalities in patients with Gaucher's disease, effect of therapy. Am J Hematol. 1996;51: 234-236.
66. Hollak CEM, Levi M, Berends F, Aerts JMFG, van Oers MHJ. Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy. Br J Haematol. 1997;96: 470-476.
67. Dolev E, Many A. Gaucher's disease and primary hyperparathyroidism in the same patient: the impact of a coincidence. Isr J Med Sci. 1987;23: 1164-1165.
68. Mankin HJ, Doppelt SH, Rosenberg AE, Barranger JA. Metabolic bone disease in patients with Gaucher's disease. In: Avioli LU, Krane SM, eds. Metabolic Bone Disease and Clinically Related Disorders. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1990:730-752.
69. Shoenfeld Y, Berliner S, Pinkhas J, Beutler E. The association of Gaucher's disease and dysproteinemias. Acta Haematol. 1980;64:241-243.
70. Liel Y, Hausmann MJ, Mozes M. Case report: serendipitous Gaucher's disease presenting as elevated erythrocyte sedimentation rate due to monoclonal gammopathy. Am J Med Sci. 1991; 301:393-394.